Year Established :
2008
Total Assets(USD) :
500,000 to 99,999,999
Total Number of Staff :
100-500
Main Competitive Advantages :
Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Buyers' Specifications Accepted,Small Orders Accepted,Quality Service
Business Type :
All,Distributor,Trading Company,Retailer,Service Provider,Manufacturer
R&D Capacity :
Own Brand
Annual Turnover(USD) :
500,000 to 99,999,999
Main Sales Markets :
North America,Central/South America,Western Europe,Asia,Middle East,Africa
Product Range :
1 Imidazole
2 1-Methylimidazole
3 1-Ethylimidazole
4 2-Methylimidazole
5 2-Ethylimidazole
6 2-Propylimidazole
7 2-lsopropylimidazole
8 2-Phenylimidazole
9 1 -lsobutyl-2-methylimidazole
10 2-Ethyl-4-methylimidazole
11 1 -Butyl-3-methylimidazolium Chloride
12 1 -Butyl-3-methylimidazolium Bromide
13 1-Butyl-3-methylimidazolium Tetrafluoroborate
14 1 -Butyl-3-methylimidazole Tetrachloroferrite
15 Sodium Imidazole
17 Glyoxal
18 1 -Ethyl-3-methylimidazolium Chloride
19 1 -Ethyl-3-methylimidazolium Bromide
20 1,1 '-Carbonyldiimidazole
21 1,2-Dimethylimidazole
Audited Supplier
Pharma Sources Insight JANUARY 2024
